肿瘤放射性粒子植入术后病区工作人员辐射防护的再认识

doi:10.7538/tws.2016.29.01.0030

摘要/Abstract

摘要：

通过对不同距离与屏蔽条件下肿瘤放射性粒子植入后患者的放射性检测，实现辐射防护个体化与最优化。随机选择35例北京大学深圳医院微创介入病区并接受¹²⁵I放射性粒子植入的患者，植入术后2 h内使用x-γ射线检测仪在不同距离处检测未屏蔽、0.25 mmPb屏蔽、0.5 mmPb屏蔽条件下患者的剂量当量率，采用统计软件包SPSS19.0对结果进行t检验分析，并按照病区工作人员平均每人每日接触患者2 h计算相应的年剂量当量。未屏蔽时，0.5 m处工作人员所受的年剂量当量小于放射工作人员限值20 mSv，2 m处接近公众限值1 mSv，4 m处相当于病室内本底；在0.25 mmPb屏蔽下，尽管零距离处35位患者的平均年剂量当量小于公众限值，但其中有6位患者的年剂量当量大于公众限值；在0.5 mmPb屏蔽下，零距离处所有患者的年剂量当量已接近本底。结果表明，¹²⁵I粒子植入后病区工作人员的工作时间、距离、屏蔽防护中，重点要做好个体化的屏蔽防护。0.25 mmPb的铅胶布是最常使用的屏蔽物，对于粒子植入数量较多或植入部位表浅的患者必要时也应使用0.5 mmPb的铅胶布屏蔽，以实现辐射防护个体化和最优化。

关键词: 肿瘤, 放射性碘粒子, 辐射防护

Abstract:

Through radiation measurement of the patients after brachytherapy with radioiodine seeds for malignant tumor at different distances and shielding condition, the importance, optimization and individualization of the radiological protection are well recognized. The 35 patients were randomly selected in the minimally invasive interventional ward of Peking University Shenzhen Hospital who underwent brachytherapy for malignant tumor with radioiodine seeds. Within 2 hours after the brachytherapy, the radiation of the patients without shielding, with 0.25 mmPb and 0.5 mmPb shielding were detected by an x-γ ray detector at different distances (equivalent dose rate). The results were analysed by SPSS19.0 t test. Annual equivalent dose was calculated by the average close contact time (two hours everyone per day). The average annual equivalent dose of the 35 patients without shielding was below 20 mSv at 0.5 meter, close to the public limit 1 mSv at 2 meters and equivalent to the background at 4 meters. Under 0.25 mmPb shielding, 6 patients’ radiation was still above the pubic limit, although the average radiation of the 35 patients was below the pubic limit; under 0.5 mmPb shielding, all patients’ radiation was nearly equivalent to the background at 0 meter. The results showed that among the time, distance and shielded protection, the individual radiological protection was especially important. The 0.25 mmPb lead cushion was the most commonly used shield. The 0.5 mmPb lead cushion also should be used in case of the large number of radioiodine seeds implantation and/or more superficial implant site, so as to ensure the individualization and optimization in radiological protection.

Key words: neoplasm, radioiodine seeds, radiological protection

胡疏;吴鸣;杨红杰;成先义;高宙;陈俊辉. 肿瘤放射性粒子植入术后病区工作人员辐射防护的再认识[J]. 同位素, 2016, 29(1): 30-35.

HU Shu;WU Ming;YANG Hong-jie;CHENG Xian-yi;GAO Zhou;CHEN Jun-hui. Recognition of Radiological Protection of Ward Staff after Brachytherapy for Malignant Tumor with Radioiodine Seeds[J]. Journal of Isotopes, 2016, 29(1): 30-35.

参考文献

［1］王俊杰,修典荣,冉维强. 放射性粒子组织间近距离治疗肿瘤［M］. 北京：北京大学医学出版社，2004.
［2］Schnell O, Schöller K, Ruge M, et al. Surgical resection plus stereotactic ¹²⁵I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma-feasibility and outcome of a combined local treatment concept［J］. Journal of Neurology, 2008, 255(10): 1495-1502. 
［3］Bartolm s H, Glaser F H, Schmidt E. Radiation exposure of the physician and medical personnel in the handling of Au-198 seeds［J］. Radiobiol Radiother (Berl), 1970, 11(6): 705-711.
［4］Bruggmoser G, Nanko N, Hodapp N. A device for rapid and reliable loading, with reduced radiation exposure, of hodt applicators with Au-198 seeds［J］. Strahlentherapie, 1984, 160(7): 425-426.
［5］马旺扣，许运龙，山常起，等. ¹²⁵I种子源治疗前后周围辐射剂量监测［J］. 中华放射医学与防护杂志，2003,23 (1)：52-53. Ma Wangkou, Xu Yunlong, Shan Changqi, et al. Radiation dose monitoring before and after the treatment of the ¹²⁵I seed source［J］. Chinese Journal of Radiological Medicine and Protection, 2003, 23(1): 52-53(in Chinese) .
［6］张继勉. 放射性粒子组织间永久插植放射治疗的辐射防护研究［J］. 中国辐射卫生, 2006,15(4):407-411. Zhang Jimian. The study of the radiation protection problem in the radionuclide interstitial implantation therapy［J］. Chinese Journal of Radiological Health, 2006, 15(4): 407-411(in Chinese).
［7］耿建华，肖泽军，杨剑，等. ¹²⁵I粒子植入治疗前列腺癌过程中医护人员受照水平的研究［J］. 中国医学装备，2014,11(10):23-25. Geng Jianhua, Xiao Zejun, Yang Jian, et al. Radiation dose for staff during interstitial I-125 seed implantation therapy for prostate cancer［J］. China Medical Equipment, 2014, 11(10): 23-25(in Chinese).
［8］Lancaster J. About radiotherapy—Part Ⅱ. Side effects and staff protection［J］. Nursing RSA, 1989, 4(3): 41-43.
［9］Dunne-Daly C F. Education and nursing care of brachytherapy patients［J］. Cancer Nursing, 1994, 17(5): 434-444.
［10］胡疏，成先义，高宙，等. ¹²⁵I粒子组织间植入近距离治疗恶性肿瘤［J］. 同位素,2011,24(1):34-38. Hu Shu, Cheng Xianyi, Gao Zhou,et al. Investigation on curative efficacy for malignant tumor by implantation of ¹²⁵I permanent brachytherapy seeds［J］. Isotopes, 2011, 24 (1): 34-38(in Chinese).
［11］吴鸣，沈迎春，胡疏，等. ¹²⁵I粒子植入治疗肿瘤残留、复发及转移病灶病人的护理与辐射防护［J］. 全科护理,2013,11(7):1975-1977. Wu Ming, Shen Yingchun, Hu Shu,et al. The care and radiation protection for the patients underwent ¹²⁵I brachytherapy for the residue, recurrence and metastasis tumor［J］. Chinese General Practice Nursing, 2013, 11(7): 1975-1977(in Chinese).
［12］国家技术监督局. GB 18871—2002中华人民共和国国家标准,电离辐射防护与辐射源安全基本标准［S］. 北京:中国国家标准出版社,2003,1(292):458-658.
［13］卓水清，陈林，张福君，等. ¹²⁵I放射性粒子植入术后患者周围辐射剂量的监测［J］. 癌症，2007,26(6):666-668. Zhuo Shuiqing, Chen Lin, Zhang Fujun,et al. Environmental radiation dose monitor after ¹²⁵I radioactive seed implantation［J］. Chinese Journal of Cancer, 2007, 26(6): 666-668(in Chinese).
［14］张金凤,文玉琴. 前列腺癌直肠超声引导下粒子植入术的护理配合［J］. 中华护理杂志，2005,40(12):944-945. Zhang Jinfeng, Wen Yuqin. Nursing cooperation during the treatment of radioactive seed implantation for prostate cancer under the guidance of rectal ultrasound［J］. Chinese Journal of Nursing,2005, 40 (12): 944-945(in Chinese).
［15］米淑敏，田素清，李秋涛，等. 放射性粒子组织间近距离治疗恶性肿瘤的护理216例［J］. 中国实用护理杂志，2005,21(9):56-57. Mi Shumin, Tian Suqing, Li Qiutao,et al. 216 cases of nursing for the patients underwent the treatment of radioactive seed implantation for malignant tumor［J］. Chinese Journal of Practical Nursing, 2005, 21(9): 56-57(in Chinese).
［16］隋爱霞，任秀英，王娟，等. 放射性¹²⁵I粒子植入治疗消化道恶性肿瘤手术病人的护理［J］. 护理实践与研究,2012,9(11):57-58. Sui Aixia, Ren Xiuying, Wang Juan, et al. Nursing for the patients during the treatment of radioactive seed implantation for malignant tumor of digestive tract［J］. Attend to Practice and Research, 2012, 9(11): 57-58(in Chinese).

[1]	赵海龙;李洪玉. 肿瘤诊断⁶⁴Cu标记药物临床研究进展[J]. 同位素, 2021, 34(1): 78-88.
[2]	李波;罗宁;曾俊杰;吴建荣;贾致军;王磊;孙志中;陈云明;张劲松. ¹²⁵I生产工艺研究进展与展望[J]. 同位素, 2020, 33(6): 366-373.
[3]	黄旭虎;李洪玉. 放射性核素标记耐久霉素细胞凋亡显像的研究进展[J]. 同位素, 2020, 33(6): 435-442.
[4]	黄金铭;于宁文. ¹²⁵I放射性粒子治疗癌症研究进展[J]. 同位素, 2020, 33(3): 186-198.
[5]	王淼;童永彭. 硼中子俘获治疗的进展及前景[J]. 同位素, 2020, 33(1): 14-26.
[6]	付华平;张晓军;麻广宇;刘健;徐晓丹;徐白萱;张锦明. 国产氟多功能模块自动化合成¹⁸F-6-氟-L-DOPA及其临床初步应用[J]. 同位素, 2018, 31(5): 298-303.
[7]	马晶鑫;伍洲;姜申德;王红亮;武志芳. 肿瘤PET分子探针3-O-(2-¹⁸F-氟乙基)-L-多巴的合成及初步生物学评价[J]. 同位素, 2018, 31(5): 310-317.
[8]	徐仲杰;涂亚辉;钟佳琪;孙雯;汪忠华;王浩然;白少飞;吴范宏. 稳定同位素标记1-(3-甲氧基苯基)-［4-(4-氟-2-甲氧基-D₃苯胺)甲基］-1,2,3-三氮唑的合成[J]. 同位素, 2018, 31(4): 241-247.
[9]	李立强;王风;刘特立;朱华;杨志. 碘-124的生产、标记及在肿瘤PET分子影像的应用[J]. 同位素, 2018, 31(3): 188-197.
[10]	陆国秀;张国旭;郝珊瑚;郭佳;张文文;王治国;张景华. PET/CT联合显像在雌激素与阿尔茨海默病相关性研究中的价值[J]. 同位素, 2017, 30(4): 276-282.
[11]	陈美洁;陈松;尹雅芙;李亚明. PET/CT在预测及评价实体肿瘤化疗疗效中的应用[J]. 同位素, 2017, 30(2): 148-152.
[12]	张健;王宁;成伟华;李忠勇;王晓静. ^99mTc标记生长抑素类似物KE108的制备及生物学评价[J]. 同位素, 2017, 30(1): 1-8.
[13]	张辉;邓君;徐乐昌;李先杰. 溢流式驻极体水氡浓度测量方法与装置[J]. 同位素, 2016, 29(4): 241-247.
[14]	李雪娜;尹雅芙;杜补林;李亚明. NOX 4对高糖代谢乳腺癌细胞侵袭转移能力的作用[J]. 同位素, 2016, 29(2): 76-81.
[15]	王荣福. 同位素示踪RRL肿瘤新生血管显像的应用[J]. 同位素, 2015, 28(4): 201-206.